JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thunnissen, F B J M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thunnissen, F B J M
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Lung Cancer
Journal of Clinical Pathology 2003;56:805-810
© 2003 BMJ Publishing Group Ltd & Association of Clinical Pathologists


REVIEW

Sputum examination for early detection of lung cancer

F B J M Thunnissen

Correspondence to:
Dr F B J M Thunnissen
Pathology C66, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, NL-6532 SZ Nijmegen, The Netherlands; e.thunnissen{at}cwz.nl
ABSTRACT
Conventional sputum cytology can be used for the detection of lung cancer, but has shown a low yield in prospective screening trials. This review focuses on the technical aspects relevant to the outcome of DNA and image analysis in sputum. Published articles are discussed in the light of the technical background. Recent developments in DNA analysis and nuclear image analysis show a clear potential to improve or refine diagnosis beyond that achieved with conventional sputum cytology examination. The challenge for future studies in DNA and nuclear analysis of sputum is to ensure high levels of quality control and to confirm these initial encouraging results.


Keywords: Sputum samples; lung cancer; early diagnosis; cytology; molecular markers

Abbreviations: LOH, loss of heterozygosity; MSP, methylation specific polymerase chain reaction; PCR, polymerase chain reaction; RT, reverse transcription




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Li, N. W. Todd, Q. Qiu, T. Fan, R. Y. Zhao, W. H. Rodgers, H.-B. Fang, R. L. Katz, S. A. Stass, and F. Jiang
Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non-Small Cell Lung Cancer
Clin. Cancer Res., January 15, 2007; 13(2): 482 - 487.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Yasufuku, T. Nakajima, K. Motoori, Y. Sekine, K. Shibuya, K. Hiroshima, and T. Fujisawa
Comparison of Endobronchial Ultrasound, Positron Emission Tomography, and CT for Lymph Node Staging of Lung Cancer.
Chest, September 1, 2006; 130(3): 710 - 718.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.